A detailed history of Congress Wealth Management LLC transactions in Repligen Corp stock. As of the latest transaction made, Congress Wealth Management LLC holds 16,733 shares of RGEN stock, worth $2.38 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,733
Previous 14,675 14.02%
Holding current value
$2.38 Million
Previous $1.85 Million 34.67%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.79 - $167.35 $246,527 - $344,406
2,058 Added 14.02%
16,733 $2.49 Million
Q2 2024

Aug 13, 2024

BUY
$120.0 - $182.95 $174,600 - $266,192
1,455 Added 11.01%
14,675 $1.85 Million
Q1 2024

Apr 18, 2024

BUY
$170.78 - $208.42 $232,602 - $283,868
1,362 Added 11.49%
13,220 $2.43 Million
Q4 2023

Feb 09, 2024

BUY
$114.17 - $185.35 $127,071 - $206,294
1,113 Added 10.36%
11,858 $2.13 Million
Q3 2023

Oct 30, 2023

BUY
$138.78 - $176.51 $148,494 - $188,865
1,070 Added 11.06%
10,745 $1.71 Million
Q2 2023

Jul 13, 2023

BUY
$138.42 - $180.31 $63,119 - $82,221
456 Added 4.95%
9,675 $1.37 Million
Q1 2023

Apr 14, 2023

BUY
$154.26 - $198.1 $238,177 - $305,866
1,544 Added 20.12%
9,219 $1.55 Million
Q4 2022

Feb 02, 2023

BUY
$162.42 - $220.56 $102,811 - $139,614
633 Added 8.99%
7,675 $1.3 Million
Q3 2022

Nov 08, 2022

BUY
$160.42 - $256.21 $190,097 - $303,608
1,185 Added 20.23%
7,042 $1.32 Million
Q2 2022

Aug 11, 2022

SELL
$140.68 - $188.02 $5.12 Million - $6.85 Million
-36,418 Reduced 86.15%
5,857 $950,000
Q1 2022

May 16, 2022

BUY
$161.19 - $257.96 $2.21 Million - $3.53 Million
13,687 Added 47.88%
42,275 $7.95 Million
Q4 2021

Feb 04, 2022

BUY
$247.59 - $304.47 $7.08 Million - $8.7 Million
28,588 New
28,588 $7.57 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.9B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Congress Wealth Management LLC Portfolio

Follow Congress Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Wealth Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Congress Wealth Management LLC with notifications on news.